Capricor Therapeutics (CAPR) Share-based Compensation (2010 - 2026)

Capricor Therapeutics' Share-based Compensation history runs 17 years deep, the most recent figure standing at $5.9 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 2198.62% year-over-year to $5.9 million; the TTM figure through Mar 2026 stood at $22.6 million (up 234.88% YoY), while the FY2025 annual figure was $17.0 million, up 73.76% from the prior year.
• Share-based Compensation was $5.9 million for Q1 2026 at Capricor Therapeutics, up from $3.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $8.9 million in Q2 2025 to a low of $257461.0 in Q1 2025.
• Historically, Share-based Compensation has averaged $2.6 million across 5 years, with a median of $2.1 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation plunged 92.12% in 2025, then jumped 2198.62% in 2026.
• A 5-year view of Share-based Compensation shows it stood at $1.1 million in 2022, then jumped by 62.14% to $1.9 million in 2023, then rose by 23.31% to $2.3 million in 2024, then soared by 67.33% to $3.8 million in 2025, then soared by 54.06% to $5.9 million in 2026.
• The last three Share-based Compensation figures came in at $5.9 million (Q1 2026), $3.8 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.